These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25579841)

  • 1. Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective.
    Lewczuk P; Mroczko B; Fagan A; Kornhuber J
    Adv Med Sci; 2015 Mar; 60(1):76-82. PubMed ID: 25579841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology.
    Angelopoulou E; Bougea A; Hatzimanolis A; Scarmeas N; Papageorgiou SG
    Cells; 2024 Jul; 13(13):. PubMed ID: 38995015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease.
    Sobów T; Flirski M; Liberski PP
    Acta Neurobiol Exp (Wars); 2004; 64(1):53-70. PubMed ID: 15190680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs as Early Biomarkers of Alzheimer's Disease: A Synaptic Perspective.
    Siedlecki-Wullich D; Miñano-Molina AJ; Rodríguez-Álvarez J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: Unique markers for diagnosis & new treatment modalities.
    Aggarwal NT; Shah RC; Bennett DA
    Indian J Med Res; 2015 Oct; 142(4):369-82. PubMed ID: 26609028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Diagnosis of Alzheimer's Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?
    Souchet B; Michaïl A; Billoir B; Braudeau J
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise to Counteract Alzheimer's Disease: What Do Fluid Biomarkers Say?
    Bonanni R; Cariati I; Cifelli P; Frank C; Annino G; Tancredi V; D'Arcangelo G
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prominent Perspective on Existing Biological Hallmarks of Alzheimer's Disease.
    Singh N; Sharma S; Ghosh KK; Gupta B; Kuca K
    Curr Top Med Chem; 2024; 24(13):1120-1133. PubMed ID: 38591203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease Biomarker Detection Using Field Effect Transistor-Based Biosensor.
    Le PG; Choi SH; Cho S
    Biosensors (Basel); 2023 Nov; 13(11):. PubMed ID: 37998162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical importance of suspected non-Alzheimer disease pathophysiology.
    Vos SJB; Delvenne A; Jack CR; Thal DR; Visser PJ
    Nat Rev Neurol; 2024 Jun; 20(6):337-346. PubMed ID: 38724589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond.
    Webber EK; Fivaz M; Stutzmann GE; Griffioen G
    Alzheimers Dement; 2023 Aug; 19(8):3701-3717. PubMed ID: 37132525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: the challenge of the second century.
    Holtzman DM; Morris JC; Goate AM
    Sci Transl Med; 2011 Apr; 3(77):77sr1. PubMed ID: 21471435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive Biomarkers for Early Detection of Alzheimer's Disease: a New-Age Perspective.
    Chimthanawala NMA; Haria A; Sathaye S
    Mol Neurobiol; 2024 Jan; 61(1):212-223. PubMed ID: 37596437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease.
    Maestú F; Cuesta P; Hasan O; Fernandéz A; Funke M; Schulz PE
    Front Hum Neurosci; 2019; 13():17. PubMed ID: 30792632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
    Dubois B; Hampel H; Feldman HH; Scheltens P; Aisen P; Andrieu S; Bakardjian H; Benali H; Bertram L; Blennow K; Broich K; Cavedo E; Crutch S; Dartigues JF; Duyckaerts C; Epelbaum S; Frisoni GB; Gauthier S; Genthon R; Gouw AA; Habert MO; Holtzman DM; Kivipelto M; Lista S; Molinuevo JL; O'Bryant SE; Rabinovici GD; Rowe C; Salloway S; Schneider LS; Sperling R; Teichmann M; Carrillo MC; Cummings J; Jack CR;
    Alzheimers Dement; 2016 Mar; 12(3):292-323. PubMed ID: 27012484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain cells linked to protection against dementia.
    Reardon S
    Nature; 2023 Oct; 622(7982):229-230. PubMed ID: 37770661
    [No Abstract]   [Full Text] [Related]  

  • 17. A review on Alzheimer's disease pathophysiology and its management: an update.
    Kumar A; Singh A; Ekavali
    Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid biomarkers in Alzheimer's disease.
    Blennow K; Mattsson N; Schöll M; Hansson O; Zetterberg H
    Trends Pharmacol Sci; 2015 May; 36(5):297-309. PubMed ID: 25840462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapies.
    Kang JH; Ryoo NY; Shin DW; Trojanowski JQ; Shaw LM
    Korean J Physiol Pharmacol; 2014 Dec; 18(6):447-56. PubMed ID: 25598657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explorative and targeted neuroproteomics in Alzheimer's disease.
    Brinkmalm A; Portelius E; Öhrfelt A; Brinkmalm G; Andreasson U; Gobom J; Blennow K; Zetterberg H
    Biochim Biophys Acta; 2015 Jul; 1854(7):769-78. PubMed ID: 25619854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.